Emerging new technologies and disruptive manufacturing concepts are providing new opportunities for pharmaceutical companies.
Tobias Rosenkranz
Advertisement
Tobias Rosenkranz is the head of biomolecule formulation for MilliporeSigma, the life science business of Merck KGaA, Darmstadt Germany.
Articles by Tobias Rosenkranz
Advertisement
Latest Updated Articles
- Seven Trends Shaping the Future of Pharmaceutical Formulation Development
Published: October 7th 2022 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
2
Drug Digest: Strategic Alliances and Technology Integration in the Evolving Biopharma Landscape
3
Takeda’s Sriman Banerjee Discusses Smart Packaging at CPHI Frankfurt 2025
4
Dosage Form Innovations: A CPHI Frankfurt Conversation with Lonza’s Frank Romanski, Part One
5
